Molecular Cytogenetic Aberrations in Tunisian Patients with Multiple Myeloma Identified by cIg-FISH in Fixed Bone Marrow Cells

作者: A. Gmidène , H. Avet-Loiseau , H. Sennana , I. Ben Abdallah , A. Khlif

DOI: 10.1159/000334878

关键词: KaryotypeMultiple myelomaImmunologyBiologyImmunoglobulin light chainBone marrowChromosomal translocationImmunoglobulin heavy chainMolecular biologyChromosomeImmunolabeling

摘要: Cytogenetic studies in multiple myeloma (MM) are hampered by the hypo-proliferative nature of plasma cells. In order to circumvent this problem, we have used a combination immunolabeling cytoplasmic Ig light chains (λ or κ) and FISH (cIg-FISH), which allowed comprehensive detection most common and/or recurrent molecular cytogenetic aberrations on fixed bone marrow cells 70 Tunisian patients. Translocations involving chromosome 14q32 region were observed 32 cases (45.7%), including 18 with t(11;14), 8 t(4;14), 2 t(14;16). Deletions 13q14 (D13S319/RB1) detected 18.6%, deletions 17p13 (TP53) 5.7% cases, respectively. Of all patients D13S319/RB1 deletion, 61.5% also carried translocation, whereas TP53 associated t(11;14) (50%) D13S319 deletion 1 case (25%). Our results suggest that there is correlation between presence translocations MM cIg-FISH more sensitive as compared conventional karyotyping detecting abnormalities disease.

参考文章(29)
J Bacovsky, V Farbiakova, J Minarik, K Indrak, V Scudla, L Dusek, M Zemanova, M Budikova, M Ordeltova, International prognostic index (IPI)--a critical comparison with five multiple myeloma staging systems in the group of 270 patients treated by conventional chemotherapy. Neoplasma. ,vol. 53, pp. 277- 284 ,(2006)
JL Lai, M Zandecki, JY Mary, F Bernardi, V Izydorczyk, M Flactif, P Morel, JP Jouet, F Bauters, T Facon, Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis Blood. ,vol. 85, pp. 2490- 2497 ,(1995) , 10.1182/BLOOD.V85.9.2490.BLOODJOURNAL8592490
S X Qian, W Xu, Y Zhu, H R Qiu, L J Chen, J Y Li, Y P Zhang, L M Duan, H Lu, Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization. Experimental Oncology. ,vol. 29, pp. 116- 120 ,(2007)
Iveta Mareschová, Lucie Kovářová, Alena Buliková, Romana Musilová, P. Kuglík, Jiří Vorlíček, Tomáš Büchler, Ludmila Bourková, Miroslav Penka, Anežka Fišerová, Zuzana Janáčková, Pavlína Váňová, Roman Hájek, J. Sobotka, V. Holubová, Detection of 13q abnormalities in multiple myeloma using immunomagnetically selected plasma cells. Neoplasma. ,vol. 49, pp. 300- 306 ,(2002)
Brian G.M. Durie, Staging and kinetics of multiple myeloma. Seminars in Oncology. ,vol. 13, pp. 300- 309 ,(1986) , 10.5555/URI:PII:0093775486900060
Niklas Zojer, Robert Königsberg, Jutta Ackermann, Elke Fritz, Susanne Dallinger, Elisabeth Krömer, Hannes Kaufmann, Lucia Riedl, Heinz Gisslinger, Susanne Schreiber, Renate Heinz, Heinz Ludwig, Heinz Huber, Johannes Drach, Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization. Blood. ,vol. 95, pp. 1925- 1930 ,(2000) , 10.1182/BLOOD.V95.6.1925
Hervé Avet-Loiseau, Jian-Yong Li, Nadine Morineau, Thierry Facon, Christophe Brigaudeau, Jean-Luc Harousseau, Bernard Grosbois, Régis Bataille, Monosomy 13 Is Associated With the Transition of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma Blood. ,vol. 94, pp. 2583- 2589 ,(1999) , 10.1182/BLOOD.V94.8.2583.420A05_2583_2589
Michael Hallek, P. Leif Bergsagel, Kenneth C. Anderson, Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process Blood. ,vol. 91, pp. 3- 21 ,(1998) , 10.1182/BLOOD.V91.1.3